95-20340. Manufacturer of Controlled Substances; Notice of Application

[Federal Register Volume 60, Number 159 (Thursday, August 17, 1995)]
[Notices]
[Pages 42903-42904]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-20340]



=======================================================================
-----------------------------------------------------------------------

[[Page 42904]]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 2, 1995, Arenol Chemical 
Corporation, 189 Meister Avenue, Somerville, New Jersey 08876, made 
application to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine (7396)...............................  I       
3,4-Methylenedioxyamphetamine (7400)..........................  I       
Difenoxin (9186)..............................................  I       
Amphetamine (1100)............................................  II      
Methamphetamine (1105)........................................  II      
------------------------------------------------------------------------

    The firm plans to manufacture Difenoxin, Amphetamine and 
Methamphetamine to produce pharmaceutical products for distribution to 
its customers; and 2,5-Dimethoxyamphetamine and 3,4-
Methylenedioxyamphetamine as intermediates for the development of other 
pharmaceutical products.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments, or objections may be addressed to the Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, United States Department of Justice, Washington, DC 
20537, Attention: DEA Federal Register Representative (CCR), and must 
be filed no later than October 16, 1995.

    Dated: August 10, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-20340 Filed 8-16-95; 8:45 am]
BILLING CODE 4410-09-M